Mediators of the Acute Inflammatory Reaction.docx

上传人:b****9 文档编号:26268058 上传时间:2023-06-17 格式:DOCX 页数:6 大小:17.99KB
下载 相关 举报
Mediators of the Acute Inflammatory Reaction.docx_第1页
第1页 / 共6页
Mediators of the Acute Inflammatory Reaction.docx_第2页
第2页 / 共6页
Mediators of the Acute Inflammatory Reaction.docx_第3页
第3页 / 共6页
Mediators of the Acute Inflammatory Reaction.docx_第4页
第4页 / 共6页
Mediators of the Acute Inflammatory Reaction.docx_第5页
第5页 / 共6页
点击查看更多>>
下载资源
资源描述

Mediators of the Acute Inflammatory Reaction.docx

《Mediators of the Acute Inflammatory Reaction.docx》由会员分享,可在线阅读,更多相关《Mediators of the Acute Inflammatory Reaction.docx(6页珍藏版)》请在冰豆网上搜索。

Mediators of the Acute Inflammatory Reaction.docx

MediatorsoftheAcuteInflammatoryReaction

10MediatorsoftheAcuteInflammatoryReaction

Theclosesimilarityoftheacuteinflammatoryreactiontodiversetypesofinjury,thehighlyorderedsuccessionofeventsextendingovermanyhourswhichfollowaninjurylastingonlyabreifperiod,andthespreadoftheinflammatoryreactiontoadjacentuninjuredtissuesallsuggestthatchemicalsubstances,liberatedwithininjuredtissues(endogenouschemicalmediators),playaroleinthegenesisoftheacuteinflammatoryreaction.

Endogenousmediatorsappeartoberesponsibleforbothvasodilatationandleucocyticcausethoseformsofincreasedvascularpermeabilitywhicharenotaresultofdirectinjurytoofendogenoussubstanceswhichcanreproduceoneormorefeaturesofacuteinflammationhavebeenidentifiedininjuredtissuesandininflammatoryexudates,butlittleisknownforcertainaboutwhichofthesepotentialmediatorsareofimportanceinparticulartypesofinflammation.

Proofoftheparticipationofaspecifiemediatorrequiresthedetectionofitspresenceinactiveformandeffectiveconcentrationduringtherelevantperiod,andinhibitionoftheresponsebyprioradministrationofspecificantagonisticdrugs.Thesecreteriahavenotbeensatisfiedforanymediatorexcepthistaminewhichhasbeenshowntoberesponsibleforthebrief,andrelativelyunimportant,initialphaseofleakageaftermanytypesofinjury.Itisthereforenotappropriatetogiveadetailedaccountofthepossiblechemicalmediatorsofiflammation,andthenoteswhichfollowontheirproductionandactionsareintentionallybrief.

Possibleendogenousmediators

Thesemaybedividedintothoseformedinplasmaandthosearisingfromtissuecells.

Plasmafactors

Theseincludeproductsofactivationandinteractionoffourmajorcascadesystems–thekinin,complement,coagulationandfibrinolyticsystems.

1.Thekininsystem.Onamolarbasisthemostpotentknownvascularpermeabilityfactorisbradykinin,anonapeptideformedbydigestionofaplasmaglycoprotein,kininogen,byaproteolyticenzyme,kallikrein,foundinnormalplasmaasitsinactiveprecursor,prekallikrein.ContactofplasmawithdamagedtissuesorwithaforeignsurfaceactivatesHagemanfactor(factorXIIofthecoagulationcascade)whichconvertsprekallikreintokallikrein.Enzymeswithkallikreinactivityarepresentinmanytissues,inurineandinglandularsecretions.Severalpeptidescloselyrelatedtobradykinincanbereleasedbysimilarenzymesystemsandarealsopowerfulpermeabilityfactors(i.e.increasevascularpermeability).Kininsaredestroyedrapidlybykininasesinplasmaandintissues,bothofwhichalsocontairkallikreinantagonists.

Beforethekininsystemwascharacterised,apartofitwasdescribedbyMilesandWilhelmunderthenameofPF/dil,whichisprobablyacombinationofseveralelementsofthekininsystemandnotaspecificsubstance.

2.Thecomplementsystem.Itsactivationbythe‘classicalpathway’isacascadereactioninwhichninemajorcomponents,someofwhicharepro-enzymes,reactsequentially,resultinginacytolyticcomplexwhichdisruptstheintegrityofcellmembranes.Asecondsequenceofativation,thealternativepathway,involvesadditionalcomponentsandby-passesthefirstthreestagesoftheclassicalcomplementcascade.

Atvariousstagesalongthecomplementcascade,biologicallyactiveby-productsarereleasedbyenzymiccleavageofcomplementcomponents.Somearepermeabilityfactorsandothershavechemotacticorchemokineticeffectsonbloodleucocytes.Theseactiveby-productscanbegeneratedalsobythedirectactionofvariousproteolyticenzymes,presentindamagedtissues,oncomplementcomponents,especiallyC3andC5.

Complementby-productsincludethefollowing.

(1)C5a,acleavageproductofthefifthcomponentofcomplement(C5),whichhasbothchemotacticandpermeability-increasingproperties.Thelatereffectispartlyadirectoneonvenularendotheliumandpartlymediatedbytriggeringreleaseofhistaminefrommastcells.C3a,aproductofC3,hassimilarbutweakerproperties,andC3aandC5aarewidelybutinappropriatelyknownasanaphylatoxins.

(2)AhighmolecularweightcomplexofC5,6and7,whichhasbeenclaimedtohavechemotacticactivity.

Formationofakinin-likesubstancebycleavageofC2haslongbeensuspectedbutitnowseemslikelythatthisisreallyakinin,productionofthichisinhibitedbyC-INHwhichalsoinhibitsactivationofcomplement.

Inthecomplexenvironmentofacuteinflammation,thecomplementsystemcanbeactivatedinvariousways,notablyasfollows.

(i)Ininfections,unionofantibodieswithmicro-organismsortheirantigenicproductscanactivatecomplement.TheendotoxinsofGramvebacteriacanactivatecomplementattheC3stageandenzymessecretedbysomebacteriaarecapableofactivatingC3andC5.

(ii)Intissueinjury,e.g.ischaemicnecrosisofheartmuscle,enzymescapableofactivatingC3andC5arereleasedfromthedyingcells.

(iii)Activatioproductsofthekinin,clottingandfibrinolyticsystems(seebelow),arecapableofactivatingcomplement.

3.Thecoagulationandfibrinolyticsystems.Thecoagulationorclottingsystembringsabouttheconversiongofsolublefibrinogentoinsolublefibrin.Biologicallyactivepeptidesarereleasedduringthisconversionandinthesubsequentlysisoffibrinbyplasmin,anenzymepresentininactiveform,plasminogen,innormalplasma.Thesepeptidescanaffectbothvascularpermeabilityandthemovementofleucocytes.

Thedifferentcascadesystemsoutlinedabovearerelatedinavarietyofways,andeachcanenhacetheactivityoftheothers.Hagemanfactorplaysakeyrole.Itisactivatedbycontactwithextravasculartissueelementsincludingbasementmembrane,bybacterialenzymesandbycertainproteolyticenzymes.Onceinflammationhasbegun,Hagemanfactorleakingthroughgapsintheendotheliumofsmallbloodvesselscanactivateallthreemediatorsystems.Elementsineachsystemcan,inturn,activatemoreHagemanfactor.

Despitethesecomplexinteractions,itseemslikelythatthemajorinflammatoryendproductsofthethreeplasmacascadesarebradykininandcomplementactivationproductsC3aandC5a.

Factorsreleasedfromtissuecells

Histamineispresentininactiveforminmastcells,eosinophilandbasophilleucocytesandplatelets.Itcanbereleasedfromthesedepotsbyinflammatorystimuli,bycomplementactivationproductsC3aandC5aandbyalysosomalproteinsecretedbypolymorphs.Histaminecanalsobesynthesisedbytheenzymehistidinedecarboxylasepresentinothertypesofcell.

Histaminecausesactivehyperaemiaandincreasedvascularpermeabilitylasting10-15minutes.Itisresponsiblefortheimmediatetransientphaseofincreasedpermeabilityseenaftermanytypesofmildinjury.

Serotonin(5-hydroxytryptamine)isfoundinlargeamountsinmastcellsandinplateletsandinlesseramountsinmanyothertypesofcell.Inratsandmice,serotoninincreasesvascularpermeabilityinasimilarwaytohistamine.Inmanitisapotentvasoconstrictorbutdoesnotincreasevascularpermeability.

Aswellashistamineandserotonin,stimulatedmastcellscanreleaseotheractiveproductsincludingSRS-Aandaneosinophilchemotacticfactorofanaphylaxis,ECF-A,whichisstronglychemotacticforeosinophils.

Prostaglandins(PG)andleukotrienes.Prostaglandinsarelong-chainhydroxy-fattyacidswhichcanbesynthesisedandreleasedbymosttypesofcells,butarenotstoredwithincells.Individualprostaglandinsdifferintheireffects.Some,includingE,andE2,arepowerfulvasodilatorsandpotentiategreatlytheincreasedpermeabilityinducedbyotheragents.Despiteearlierclaimstheydonotthemselvesincreasevascularpermeability.Otherprostaglandinscaninhibitcertainoftheprocessesofinflammation.ProstaglandinI2(prostacyclin),secretedbyvascularendothelium,hasapowerfulinhibitorydffectonplateletaggregationandappearstoinhibitalsotheadherenceofleucocytestovascularendothelium.ThromboxaneA2,liberatedfromboodplatelets,hastheoppositeeffect,beingamostpowerfulplateletaggregatingagent.Firmevidenceoftheroleofprostaglandinsininflammationisscanty,buttheanti-inflammatoryeffectofaspirinandrelateddrugshasbeenshowntobeduetoinhibitionofprostaglandinsynthetase(cyclo-oxygenase),anenzymeconcernedinthesynthesisofprostaglandins.

Leukotrienes.Morerecently,compoundstermedleukotrienes(LTs)havebeenproposedeasmediatorsofacuteinflammation.Theyareproducedbytheactionoflipoxygenaseonarachidonicacid.LTB4issecretedbyneutrophilpolymorphsininflammatorylesions:

itischemotaciticforneutrophilandeosinophilpolymorpinsandmonocytes.Onceafewneutrophilpolymorphshavemigratedintoinflamedtissues,releaseofLTB4presumablypromotestheaccumulationofmorepolymorphs.LTC4andLTD4aresecretedbyactivatedmastcells:

theyarecapableofinducingvasculardilatationandincreasedvenularpermeability.SRS-A(slow-reactingsubstanceofanaphylaxis)isamixtureofLTC4andLTD4,andhasbeenshowntobeinvolvedinthebronchospasmofasthma.

Lysosomalcomponents.Potentialmediatorsmaybereleasedfromlysosomes,especiallyfromneutrophilpolymorphs,butalsofromothercellsincludingmacrophagesandplatelets.Themostimportantlysosomalproductsininflammationappeartobecationicproteinsandneutralproteases.Cationicproteinscanincreasepermeability,eitherdirectlyorviamastcells,andarechemotactictomonocytes.Theneutralproteasesareinvolvedintissuedamageaftermanytypesofinjury,andcangeneratechemotacticfactorsbycleavingC5andprobablyalsoC3.

Lymp

展开阅读全文
相关资源
猜你喜欢
相关搜索

当前位置:首页 > 高中教育 > 初中教育

copyright@ 2008-2022 冰豆网网站版权所有

经营许可证编号:鄂ICP备2022015515号-1